Single Ventricle Heart Disease clinical trials at UCSF

1 research study open to eligible people

Single ventricle heart disease occurs when one ventricle of the heart doesn't grow correctly. UCSF is investigating udenafil, which is given orally, to test its safety and effects. UCSF also leads studies on how such patients can better handle physical activity.

Showing trials for

  • Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

    open to eligible people ages 12-18

    This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo for the treatment of adolescent who have had the Fontan procedure.

    San Francisco, California and other locations

Our lead scientists for Single Ventricle Heart Disease research studies include .

Last updated: